Advanced search
Publication Cover
Journal of Asthma Volume 57, 2020 - Issue 2
Submit an article Journal homepage
401
Views
5
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Effectiveness and safety of omalizumab in severe, persistent IgE-mediated asthma in pediatric and adult patients: a real-world observational study in Egyptian population

Hesham N. TarrafDepartment of Internal Medicine, Cairo University, Cairo, Egypt; Correspondence[email protected]
, MD,
Hossam Hosny MasoudPulmonology Department (Chest), Cairo University, Cairo, Egypt;
, MD,
Mohamed ZidanChest Diseases Department, Alexandria University, Alexandria, Egypt;
, MD &
Begad WahbaNovartis Pharma S.A.E., Cairo, Egypt
, MD
Pages 160-166 | Received 11 Jun 2018, Accepted 24 Nov 2018, Published online: 28 Dec 2018

References

  • Global Initiative for Asthma. Global strategy for asthma management and prevention updated 2016. Available from: http://www.ginasthma.org/wp-content/uploads/2016/04/GINA-Appendix-2016-final.pdf. [last accessed 15 February 2018]
  • The Global Asthma Report 2014. The Global Asthma Network. Available from: http://www.globalasthmareport.org/2014/resources/Global_Asthma_Report_2014.pdf [last accessed 15 February 2018].
  • Georgy V, Fahim HI, El-Gaafary M, Walters S. Prevalence and socioeconomic associations of asthma and allergic rhinitis in northern Africa. Eur Respir J 2006;28:756–762. doi:10.1183/09031936.06.00089005.
  • Zedan M, Settin A, Farag M, Ezz-Elregal M, Osman E, Fouda A. Prevalence of bronchial asthma among Egyptian school children. Egyptian J Bronchol 2009;3:124–130.
  • Al Dhduh MAA, Sabri NAM, Fouda FM. Prevalence and severity of allergic diseases among egyptian pediatric in different Egyptian areas. Int J Pharm Sci Res 2015;2:107–111.
  • Abdallah AM, Sanusy KA, Said WSH, Mahran DG, Mohamed-Hussein AAR. Epidemiology of bronchial asthma among preparatory school children in Assiut district. Egypt J Pediatr Allergy Immunol 2012;10:109–117.
  • Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med 2006;100:1139–1151.
  • Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 2006;55:420–426.
  • Ortega VE, Meyers DA. Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine. J Allergy Clin Immunol 2014;133:16–26.
  • Rumpel JA, Ahmedani BK, Peterson EL, Wells KE, Yang M, Levin AM, Yang JJ, et al. Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma. J Allergy Clin Immunol 2012;130:1302–1306.
  • Molimard M, de Blay F, Didier A, Le Gros V. Effectiveness of omalizumab (Xolair) in the first patients treated in real-life practice in France. Respir Med 2008;102:71–76.
  • Korn S, Thielen A, Seyfried S, Taube C, Kornmann O, Buhl R. Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany. Respir Med 2009;103:1725–1731. doi:10.1016/j.rmed.2009.05.002.
  • Rottem M. Omalizumab reduces corticosteroid use in patients with severe allergic asthma: real-life experience in Israel. J Asthma 2012;49:78–82. doi:10.3109/02770903.2011.637598.
  • Brusselle G, Michils A, Louis R, Dupont L, Van de Maele B, Delobbe A, Pilette C, et al. “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study. Respir Med 2009;103:1633–1642.
  • Cazzola M, Camiciottoli G, Bonavia M, Gulotta C, Ravazzi A, Alessandrini A, Caiaffa MF, et al. Italian real-life experience of omalizumab. Respir Med 2010;104:1410–1416.
  • Siergiejko Z, Świebocka E, Smith N, Peckitt C, Leo J, Peachey G, Maykut R. Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients. Curr Med Res Opin 2011;27:2223–2228. doi:10.1185/03007995.2011.620950.
  • Braunstahl GJ, Chen CW, Maykut R, Georgiou P, Peachey G, Bruce J. The eXpeRience registry: the ‘real-world’ effectiveness of omalizumab in allergic asthma . Respir Med 2013;107:1141–1151.
  • Niven RM, Saralaya D, Chaudhuri R, Masoli M, Clifton I, Mansur AH, Hacking V, et al. Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study). BMJ Open 2016;6:e011857. doi:10.1136/bmjopen-2016-011857.
  • Li J, Kang J, Wang C, Yang J, Wang L, Kottakis I, Humphries M, et al. Omalizumab improves quality of life and asthma control in Chinese patients with moderate to severe asthma: a randomized phase III study. Allergy Asthma Immunol Res 2016;8:319–328. doi:10.4168/aair.2016.8.4.319.
  • Odajima H, Ebisawa M, Nagakura T, Fujisawa T, Akasawa A, Ito K, Doi S, et al. Omalizumab in Japanese children with severe allergic asthma uncontrolled with standard therapy. Allergol Int 2015;64:364–370. doi:10.1016/j.alit.2015.05.006.
  • O'Byrne PM, Reddel HK, Eriksson G, Ostlund O, Peterson S, Sears MR, Jenkins C, et al. Measuring asthma control: a comparison of three classification systems. Eur Respir J 2010;36:269–276. doi:10.1183/09031936.00124009.
  • Zinman R, Bethune P, Camfield C, Fitzpatrick E, Gordon K. An observational asthma study alters emergency department use: the Hawthorne effect. Pediatr Emerg Care 1996;12:78–80. doi:10.1097/00006565-199604000-00002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.